Literature DB >> 7897626

Mutation in DHP receptor alpha 1 subunit (CACLN1A3) gene in a Dutch family with hypokalaemic periodic paralysis.

R H Boerman1, R A Ophoff, T P Links, R van Eijk, L A Sandkuijl, A Elbaz, J E Vale-Santos, A R Wintzen, J C van Deutekom, D E Isles.   

Abstract

Hypokalaemic periodic paralysis (HypoPP) is characterised by transient attacks of muscle weakness of varying duration and severity accompanied by a drop in serum potassium concentration during the attacks. The largest known HypoPP family is of Dutch origin and consists of 277 members in the last five generations, 55 of whom have HypoPP inherited in an autosomal dominant pattern. Forty-eight persons including 28 patients with a proven diagnosis of HypoPP were used for linkage analysis. Microsatellite markers were used to exclude 45 to 50% of the genome and linkage to chromosome 1q31-32 was found. No recombinants were found between HypoPP and D1S412 and a microsatellite contained within the DHP receptor alpha 1 subunit (CACLN1A3) gene. A previously reported G to A mutation causing an arginine to histidine substitution at residue 528 in the transmembrane segment IIS4 of the CACLN1A3 gene was shown in patients by restriction analysis of genomic PCR products.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7897626      PMCID: PMC1050178          DOI: 10.1136/jmg.32.1.44

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  29 in total

1.  LETHAL GENES AND ANALYSIS OF DIFFERENTIATION.

Authors:  S GLUECKSOHN-WAELSCH
Journal:  Science       Date:  1963-12-06       Impact factor: 47.728

2.  The muscle fiber conduction velocity and power spectra in familial hypokalemic periodic paralysis.

Authors:  M J Zwarts; T W van Weerden; T P Links; H T Haenen; H J Oosterhuis
Journal:  Muscle Nerve       Date:  1988-02       Impact factor: 3.217

3.  Restoration of excitation-contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA.

Authors:  T Tanabe; K G Beam; J A Powell; S Numa
Journal:  Nature       Date:  1988-11-10       Impact factor: 49.962

4.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.

Authors:  J L Weber; P E May
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

5.  Induction of calcium currents by the expression of the alpha 1-subunit of the dihydropyridine receptor from skeletal muscle.

Authors:  E Perez-Reyes; H S Kim; A E Lacerda; W Horne; X Y Wei; D Rampe; K P Campbell; A M Brown; L Birnbaumer
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

6.  Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene.

Authors:  B Fontaine; T S Khurana; E P Hoffman; G A Bruns; J L Haines; J A Trofatter; M P Hanson; J Rich; H McFarlane; D M Yasek
Journal:  Science       Date:  1990-11-16       Impact factor: 47.728

7.  Permanent muscle weakness in familial hypokalaemic periodic paralysis. Clinical, radiological and pathological aspects.

Authors:  T P Links; M J Zwarts; J T Wilmink; W M Molenaar; H J Oosterhuis
Journal:  Brain       Date:  1990-12       Impact factor: 13.501

8.  Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters.

Authors:  R Rüdel; F Lehmann-Horn; K Ricker; G Küther
Journal:  Muscle Nerve       Date:  1984-02       Impact factor: 3.217

9.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

10.  Paramyotonia congenita or hyperkalemic periodic paralysis? Clinical and electrophysiological features of each entity in one family.

Authors:  S M de Silva; R W Kuncl; J W Griffin; D R Cornblath; S Chavoustie
Journal:  Muscle Nerve       Date:  1990-01       Impact factor: 3.217

View more
  6 in total

1.  Neuropathology of degenerative cell death in Caenorhabditis elegans.

Authors:  D H Hall; G Gu; J García-Añoveros; L Gong; M Chalfie; M Driscoll
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

2.  Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene.

Authors:  Haiyan Zhou; Suzanne Lillis; Ryan E Loy; Farshid Ghassemi; Michael R Rose; Fiona Norwood; Kerry Mills; Safa Al-Sarraj; Russell J M Lane; Lucy Feng; Emma Matthews; Caroline A Sewry; Stephen Abbs; Stefan Buk; Michael Hanna; Susan Treves; Robert T Dirksen; Gerhard Meissner; Francesco Muntoni; Heinz Jungbluth
Journal:  Neuromuscul Disord       Date:  2010-01-18       Impact factor: 4.296

Review 3.  Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder.

Authors:  Bertrand Fontaine; Emmanuel Fournier; Damien Sternberg; Savine Vicart; Nacira Tabti
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

4.  PharmGKB summary: very important pharmacogene information for CACNA1S.

Authors:  Katrin Sangkuhl; Robert T Dirksen; Maria L Alvarellos; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2020-02       Impact factor: 2.000

5.  SCP2 variant is associated with alterations in lipid metabolism, brainstem neurodegeneration, and testicular defects.

Authors:  Melanie Galano; Shereen Ezzat; Vassilios Papadopoulos
Journal:  Hum Genomics       Date:  2022-08-22       Impact factor: 6.481

6.  The role of CACNA1S in predisposition to malignant hyperthermia.

Authors:  Danielle Carpenter; Christopher Ringrose; Vincenzo Leo; Andrew Morris; Rachel L Robinson; P Jane Halsall; Philip M Hopkins; Marie-Anne Shaw
Journal:  BMC Med Genet       Date:  2009-10-13       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.